Shareholders Sue Amgen Over Anemia Drugs
Biotech company Amgen Inc. has been hit with a class action securities lawsuit alleging that the drug maker misled shareholders by concealing the results of a clinical study involving two of...To view the full article, register now.
Already a subscriber? Click here to view full article